What? How will this left-field (*) development work, I wonder? I need to spend some time contemplating what this means for my company. (*) I have to say, generally, my starting point is to not be a fan of things coming out of left-field
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025